Published in Genet Med on July 31, 2001
Drosophila spalt/spalt-related mutants exhibit Townes-Brocks' syndrome phenotypes. Proc Natl Acad Sci U S A (2003) 0.91
A comprehensive review of the genetic basis of cleft lip and palate. J Oral Maxillofac Pathol (2012) 0.89
OTX2 duplication is implicated in hemifacial microsomia. PLoS One (2014) 0.84
Distinctive spine abnormalities in patients with Goldenhar syndrome: tomographic assessment. Eur Spine J (2014) 0.79
Hemifacial microsomia with pulmonary hypoplasia. BMJ Case Rep (2010) 0.75
Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg (1982) 12.85
Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell (1997) 7.47
Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell (1996) 5.10
Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med (1992) 4.76
Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell (1987) 3.60
Arteriovenous malformations of the head and neck: natural history and management. Plast Reconstr Surg (1998) 3.42
PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet (1999) 3.22
Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation. Am J Med Genet (1999) 3.02
Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg (1999) 2.99
Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest (1994) 2.97
A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell (1993) 2.80
Hemangiomas and vascular malformations of infancy and childhood. Pediatr Clin North Am (1993) 2.69
Vascular tumors and vascular malformations (new issues). Adv Dermatol (1997) 2.48
A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet (1997) 2.22
Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg (1983) 2.20
Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest (2001) 2.20
Nonsyndromic cleft lip with or without cleft palate: evidence of linkage to BCL3 in 17 multigenerational families. Am J Hum Genet (1995) 2.12
Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a. Pediatrics (1999) 2.12
The effect of TRPM7 suppression on the proliferation, migration and osteogenic differentiation of human dental pulp stem cells. Int Endod J (2013) 1.97
Pyogenic granuloma (lobular capillary hemangioma): a clinicopathologic study of 178 cases. Pediatr Dermatol (1991) 1.96
Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy. J Pediatr (1998) 1.95
Application of the biological principle of induced osteogenesis for craniofacial defects. Lancet (1981) 1.92
Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes. Am J Hum Genet (1999) 1.88
Germline and germline mosaic PTEN mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis. Hum Mol Genet (2000) 1.84
Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet (1994) 1.83
Soft-tissue vascular anomalies: utility of US for diagnosis. Radiology (2000) 1.82
Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK. Am J Hum Genet (2001) 1.81
Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg (1997) 1.76
American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genet Med (2001) 1.70
Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1. Am J Med Genet (2000) 1.70
Donor-site morbidity after harvesting rib and iliac bone. Plast Reconstr Surg (1984) 1.67
Childhood hemangiomas and vascular malformations: angiographic differentiation. AJR Am J Roentgenol (1983) 1.64
A gene for familial venous malformations maps to chromosome 9p in a second large kindred. J Med Genet (1995) 1.59
Vascular anomalies of the maxillofacial region. J Oral Maxillofac Surg (1986) 1.57
KRIT1 is mutated in hyperkeratotic cutaneous capillary-venous malformation associated with cerebral capillary malformation. Hum Mol Genet (2000) 1.53
Human NELL-1 expressed in unilateral coronal synostosis. J Bone Miner Res (1999) 1.52
Gastrointestinal manifestations of vascular anomalies in childhood: varied etiologies require multiple therapeutic modalities. J Pediatr Surg (1998) 1.52
Stage III neuroblastoma over 1 year of age at diagnosis: improved survival with intensive multimodality therapy including multiple alkylating agents. J Clin Oncol (1993) 1.51
Klippel-Trenaunay syndrome and spinal arteriovenous malformations: an erroneous association. AJNR Am J Neuroradiol (2010) 1.49
The O.M.E.N.S. classification of hemifacial microsomia. Cleft Palate Craniofac J (1991) 1.49
NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight. Neurology (2007) 1.47
Skeletal changes associated with vascular malformations. Plast Reconstr Surg (1984) 1.46
Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol (2000) 1.43
Genetic mapping of cleidocranial dysplasia and evidence of a microdeletion in one family. Hum Mol Genet (1995) 1.42
Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly. Plast Reconstr Surg (2001) 1.42
Clinical and ultrastructural studies of Romberg's hemifacial atrophy. Plast Reconstr Surg (1990) 1.40
Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1. Am J Med Genet (1999) 1.40
Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells. Am J Pathol (2001) 1.40
Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia. Am J Hum Genet (1999) 1.39
Computer-assisted three-dimensional planning in craniofacial surgery. Plast Reconstr Surg (1993) 1.38
In vitro characteristics of endothelium from hemangiomas and vascular malformations. Surgery (1982) 1.38
A gene for inherited cutaneous venous anomalies ("glomangiomas") localizes to chromosome 1p21-22. Am J Hum Genet (1999) 1.37
Deletion of the entire NF1 gene detected by the FISH: four deletion patients associated with severe manifestations. Am J Med Genet (1995) 1.37
Mast cells in hemangiomas and vascular malformations. Pediatrics (1982) 1.37
Distal 8p deletion (8)(p23.1): an easily missed chromosomal abnormality that may be associated with congenital heart defect and mental retardation. Am J Med Genet (1996) 1.36
Vascular malformations of the upper limb: a review of 270 patients. J Hand Surg Am (1999) 1.36
E-selectin is present in proliferating endothelial cells in human hemangiomas. Am J Pathol (1996) 1.35
Biological classification of soft-tissue vascular anomalies: MR correlation. AJR Am J Roentgenol (1991) 1.31
Four common glomulin mutations cause two thirds of glomuvenous malformations ("familial glomangiomas"): evidence for a founder effect. J Med Genet (2005) 1.30
Classification of pediatric vascular lesions. Plast Reconstr Surg (1982) 1.30
Molecular genetics of vascular malformations. Matrix Biol (2001) 1.29
Vascular anomalies. A primer for pediatricians. Pediatr Clin North Am (1998) 1.28
Sialadenitis in childhood. Am J Surg (1978) 1.27
Facial fractures in children: an analysis of 122 fractures in 109 patients. Plast Reconstr Surg (1977) 1.25
Increased apoptosis coincides with onset of involution in infantile hemangioma. Microcirculation (1998) 1.25
Facial infiltrating lipomatosis. Plast Reconstr Surg (2001) 1.25
Major intravenous extravasation injuries. Am J Surg (1979) 1.23
Marked female predilection in some syndromes associated with facial hemangiomas. Am J Med Genet (1994) 1.22
Isolation and characterization of human heparin. Biochemistry (1992) 1.21
The limits of tracheal resection with primary anastomosis: further anatomical studies in man. J Thorac Cardiovasc Surg (1968) 1.21
The innervation of the human larynx. Arch Otolaryngol Head Neck Surg (1993) 1.19
Connexin 26 studies in patients with sensorineural hearing loss. Arch Otolaryngol Head Neck Surg (2001) 1.16
Genetic heterogeneity of Saethre-Chotzen syndrome, due to TWIST and FGFR mutations. Am J Hum Genet (1998) 1.16
Macroglossia: a review of the condition and a new classification. Plast Reconstr Surg (1986) 1.16
Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg (1999) 1.16
Congenital hemangioma: evidence of accelerated involution. J Pediatr (1996) 1.14
Hepatic vascular anomalies in infancy: a twenty-seven-year experience. J Pediatr (1996) 1.12
Optimum pH for nuclear sex identification using quinacrine. Clin Genet (1975) 1.11
NF1 microdeletion syndrome: refined FISH characterization of sporadic and familial deletions with locus-specific probes. Am J Hum Genet (2000) 1.09
Frontal plagiocephaly: synostotic, compensational, or deformational. Plast Reconstr Surg (1992) 1.08
Cerebral vasculopathy and neurologic sequelae in infants with cervicofacial hemangioma: report of eight patients. Radiology (1998) 1.07
Induced osteogenesis for repair and construction in the craniofacial region. Plast Reconstr Surg (1980) 1.07
Vascular anomalies: classification, diagnosis, and natural history. Facial Plast Surg Clin North Am (2001) 1.07
The role of matrix metalloproteinase activity in the maturation of human capillary endothelial cells in vitro. J Cell Sci (1999) 1.05
Fate of mineralized and demineralized osseous implants in cranial defects. Calcif Tissue Int (1981) 1.05
The current management of vascular birthmarks. Pediatr Dermatol (1993) 1.04
Intracranial vascular anomalies in patients with periorbital lymphatic and lymphaticovenous malformations. AJNR Am J Neuroradiol (2007) 1.03
Complex spinal-paraspinal fast-flow lesions in CLOVES syndrome: analysis of clinical and imaging findings in 6 patients. AJNR Am J Neuroradiol (2011) 1.03
CHARGE association in a child with de novo inverted duplication (14)(q22-->q24.3). Am J Med Genet (1995) 1.02
Quantifying the spread of botulinum toxin through muscle fascia. Laryngoscope (1991) 1.01
Deletion of the entire NF1 gene causing distinct manifestations in a family. Am J Med Genet (1997) 1.00
Polyethylene glycol/microfibrillar collagen composite as a new resorbable hemostatic bone wax. J Biomed Mater Res (1998) 0.99
Molecular basis of vascular anomalies. Trends Cardiovasc Med (1998) 0.98
Tissue expansion in children: a retrospective study of complications. Ann Plast Surg (1997) 0.98
Safety and clinical efficacy of Onyx for embolization of extracranial head and neck vascular anomalies. AJNR Am J Neuroradiol (2011) 0.98
The infant with a vascular tumor. Semin Perinatol (1999) 0.97